MGTX · MeiraGTx Holdings plc
United States · RS rating 39 · As of 2026-11-03
| Price | 9.52 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 30 / 27 / 56 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 40 / 35 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +400.0% |
| Sales growth Q/Q | +18281.5% |
| Distance from 52-week high | +36.4% |
| Market cap (USD) | $862.6M |